CHS INC — fact timeline

CHS INC reported second quarter of fiscal year 2026 ended February 28, 2026 results: revenue $8.4 billion, net income $147.1 million.

“CHS Inc., a global agribusiness and the nation’s leading cooperative, today released results for its second quarter of fiscal year 2026. The company reported a net loss of $147.1 million and revenues of $8.4 billion for the quarter that ended February 28, 2026, compared to a net loss of $75.8 million and revenues of $7.8 billion in the second quarter of fiscal year 2025.”

CHS INC amended credit facility of $200 million to $250 million with Coöperatieve Rabobank U.A., New York Branch maturing August 26, 2026.

“The Omnibus Amendment extends the scheduled term of the Company’s repurchase financing facility under the Framework Agreement to August 26, 2026 and increases the Funding Limit (as defined in the Framework Agreement) from $200 million to $250 million.”

CHS INC amended credit facility with MUFG Bank, Ltd. maturing August 26, 2026.

“The Receivables Purchase Agreement Amendment further amends and restates the Receivables Purchase Agreement to add BBVA via joinder to the Receivables Purchase Agreement and other Transaction Documents as a Committed Purchaser (as defined in the Receivables Purchase Agreement) and a Purchaser Agent (as defined in the Receivables Purchase Agreement) and extend the term of the Company’s receivables and loans securitization facility provided under the Receivables Purchase Agreement to August 26, 2026, unless terminated earlier pursuant to the terms of the Receivables Purchase Agreement.”

CHS INC incurred senior notes of $250,000,000 with the accredited investors signatory thereto (collectively, the "Purchasers") at 6.13% maturing July 16, 2039.

“(iv) Series GG Notes in the aggregate principal amount of $250,000,000 with a maturity date of July 16, 2039 (the “Series GG Notes" together with the Series DD Notes, the Series EE Notes and the Series FF Notes, the “Notes")”

CHS INC incurred senior notes of $150,000,000 with the accredited investors signatory thereto (collectively, the "Purchasers") at 6.05% maturing July 16, 2037.

“(iii) Series FF Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2037 (the “Series FF Notes")”

CHS INC incurred senior notes of $150,000,000 with the accredited investors signatory thereto (collectively, the "Purchasers") at 5.93% maturing July 16, 2034.

“(ii) Series EE Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2034 (the “Series EE Notes")”

CHS INC incurred senior notes of $150,000,000 with the accredited investors signatory thereto (collectively, the "Purchasers") at 5.84% maturing July 16, 2032.

“On April 18, 2024, CHS Inc. (the “Company”) entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with the accredited investors signatory thereto (collectively, the “Purchasers”), pursuant to which the Company will issue and sell, in a private placement, its, (i) Series DD Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2032 (the “Series DD Notes")”

CHS INC entered into Note Purchase Agreement with the accredited investors signatory thereto (collectively, the "Purchasers") valued at $700,000,000 (effective 2024-04-18).

“On April 18, 2024, CHS Inc. (the “Company”) entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with the accredited investors signatory thereto (collectively, the “Purchasers”), pursuant to which the Company will issue and sell, in a private placement, its, (i) Series DD Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2032 (the “Series DD Notes”), (ii) Series EE Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2034 (the “Series EE Notes”), (iii) Series FF Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2037 (the “Series FF Notes”) and (iv) Series GG Notes in the aggregate principal amount of $250,000,000 with a maturity date of July 16, 2039 (the “Series GG Notes” together with the Series DD Notes, the Series EE Notes and the Series FF Notes, the “Notes”).”

CHS INC reported financial results for its quarter ended February 29, 2024.

“On April 3, 2024, CHS Inc. issued a press release announcing its results of operations for its quarter ended February 29, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.”

CHS INC: Amendments to bylaws: decrease Region 1 representative directors from four to three and increase Region 7 from one to two; deduct dividends from patronage net income; allow Board to add up to 35% additional patronage income to capital reserve.

“At the Annual Meeting, the members of CHS approved amendments (the “ Amendments ”) to CHS’s bylaws (the “ Bylaws ”) to: (1) decrease the number of representative directors in Region 1 from four to three directors and increase the number of representative directors in Region 7 from one to two directors; (2) provide that dividends paid by CHS, including dividends paid with respect to CHS preferred stock, will be deducted when calculating the net income or net loss of an allocation unit from patronage business; and (3) provide the Board with the authority to add an additional amount of patronage income not to exceed 35% to the capital reserve to provide additional reserves for the needs of CHS’s business.”

Scott Cordes was elected as Second Vice Chairman of the Board at CHS INC.

“Scott Cordes was elected as Second Vice Chairman of the Board”

C.J. Blew was elected as First Vice Chairman of the Board at CHS INC.

“C.J. Blew was elected as First Vice Chairman of the Board”

Anthony Rossman was elected as Director at CHS INC.

“Newly elected director Anthony Rossman succeeds former director Perry Meyer, who retired from the Board on December 8, 2023”

Perry Meyer retired as Director at CHS INC.

“Newly elected director Anthony Rossman succeeds former director Perry Meyer, who retired from the Board on December 8, 2023”

CHS INC reported fiscal year ended Aug. 31, 2023 results: revenue $45.6 billion, net income $1.9 billion.

“for the fiscal year ended Aug. 31, 2023, compared to $1.7 billion for fiscal year 2022. Key drivers for fiscal year 2023 financial results include: • Consolidated revenues of $45.6 billion for fiscal year 2023 compared to $47.8 billion for fiscal year 2022. • Our Energy segment delivered strong earnings, reflecting continued favorable market conditions in our”

CHS INC amended Thirteenth Amendment to Amended and Restated Receivables Purchase Agreement with Cofina Funding, LLC; Santander Bank, National Association; Banco Santander S.A., New York Branch; MUFG Bank, Ltd. valued at Specified Purchase Termination Date, extension of Purchase Termination Date, SBNA's exit and BSNY's (effective 2023-08-29).

“On August 29, 2023, CHS Inc. (the “ Company” ) entered into a Thirteenth Amendment (the “ Receivables Purchase Agreement Amendment” ), by and among Cofina Funding, LLC (“ Cofina Funding” ), an indirect subsidiary of the Company, as seller, the Company, as servicer, and, solely with respect to Section 7 of the Receivables Purchase Agreement Amendment, as the performance guarantor, Santander Bank, National Association (“ SBNA ”), as an exiting committed purchaser and an exiting purchaser agent, Banco Santander S.A., New York Branch (“ BSNY ”), as a new committed purchaser and a new purchaser agent, each of the other conduit purchasers, committed purchasers and purchaser agents set forth on the signature pages thereto and MUFG Bank, Ltd. (f/k/a The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch), as administrative agent (“ MUFG” ), to that certain Amended and Restated Receivables Purchase Agreement, dated as of July 18, 2017, by and among Cofina Funding, the Company, the purchasers a”

CHS INC reported its third quarter ended May 31, 2023 results: net income $547.5 million.

“CHS Inc., the nation's leading agribusiness cooperative, today released results for its third quarter ended May 31, 2023. The company reported quarterly net income of $547.5 million compared to a record third quarter net income of $576.6 million in fiscal year 2022.”

CHS INC incurred credit facility of $200 million with Coöperatieve Rabobank, U.A., New York Branch.

“Under the Repurchase Facility, CHS and CHS Capital may each request that the MFA Buyer transfer funds to them in exchange for a sale and transfer of certain eligible loans owing to CHS or CHS Capital, as applicable (the “ Eligible Loans ”), and certain eligible accounts receivable owing to CHS or CHS Capital, as applicable (the “ Eligible Accounts ”) and the related transfer of securities from CHS and CHS Capital, as applicable, representing such underlying transfer of Eligible Loans and Eligible Receivables (the “ Purchased Securities ”), with a simultaneous agreement by CHS or CHS Capital, as applicable, to repurchase Purchased Securities from time to time through the transfer funds to the MFA Buyer at a date certain or on the MFA Buyer’s demand (collectively, the “Transactions”). The aggregate obligations of CHS and CHS Capital owed to the MFA Buyer in exchange for the obligation to repurchase the Purchased Securities is not to exceed $200 million at any time outstanding.”

CHS INC entered into Repurchase Facility (Master Framework Agreement and 1996 SIFMA Master Repurchase Agreements) with Coöperatieve Rabobank, U.A., New York Branch valued at $200,000,000 (effective 2023-07-11).

“On July 11, 2023, (i) the Company entered into a Master Framework Agreement (the “ Framework Agreement ”) by and among the Company, as a seller and as agent for the sellers, CHS Capital, LLC (“ CHS Capital ”) as a seller, and Coöperatieve Rabobank, U.A., New York Branch, as buyer (the “ MFA Buyer ”), (ii) the Company entered into a 1996 SIFMA Master Repurchase Agreement (the “ Company MRA ”) between the Company and the MFA Buyer in connection with the Framework Agreement, including Annex I thereto (and as amended thereby), and (iii) CHS Capital entered into a 1996 SIFMA Master Repurchase Agreement (together with the Framework Agreement and the Company MRA, the “ Repurchase Facility ”) between CHS Capital and the MFA Buyer in connection with the Framework Agreement, including Annex I thereto (and as amended thereby).”

CHS INC incurred revolving credit of $2,800,000,000 with CoBank, ACB and Sumitomo Mitsui Banking Corporation at Term SOFR Rate, plus an applicable margin maturing April 21, 2028.

“The 2023 Revolving Credit Agreement provides for a committed revolving credit facility in the amount of $2,800,000,000, subject to an increase option under the 2023 Revolving Credit Agreement to an aggregate committed amount not exceeding $3,500,000,000. The 2023 Revolving Credit Agreement expires on April 21, 2028”

CHS INC amended 2015 Term Loan Credit Agreement Amendment (effective 2023-04-21).

“In connection with the execution of the 2023 Revolving Credit Agreement, on April 21, 2023, the Company also entered into a Fourth Amendment (the "2015 Term Loan Credit Agreement Amendment") to that certain 2015 Credit Agreement (10-Year Term Loan) (the "2015 Term Loan Credit Agreement"), dated as of September 4, 2015, as amended by the First Amendment to the 2015 Term Loan Credit Agreement, dated as of June 30, 2016, as amen”

CHS INC amended 2023 Third Amended and Restated Credit Agreement (5-Year Revolving Loan) with CoBank, ACB, and other lenders valued at $2,800,000,000 (effective 2023-04-21).

“On April 21, 2023, CHS Inc. (the "Company") entered into a 2023 Third Amended and Restated Credit Agreement (5-Year Revolving Loan) (the "2023 Revolving Credit Agreement") with CoBank, ACB ("CoBank"), for its own benefit as a lender and as the administrative agent and the bid agent for the benefit of the present and future lenders, Sumitomo Mitsui Banking Corporation, for its own benefit as a lender and as the syndication agent, and the other lenders thereto, which 2023 Revolving Credit Agreement amends and restates the 2019 Amended and Restated Credit Agreement (5-Year Revolving Loan) (the "2019 Revolving Credit Agreement"), dated as of July 16, 2019”

CHS INC reported second quarter ended February 28, 2023 results: revenue $11.3 billion, net income $292.3 million.

“to net income of $671.0 million and revenues of $21.2 billion recorded in the first half of fiscal year 2022. Fiscal 2023 second quarter highlights include: • Revenues of $11.3 billion compared to $10.3 billion in the second quarter of fiscal year 2022, a year-over-year increase of 9%. • Strong refining margins and market conditions in our refined fuels”

CHS INC incurred senior notes of $150,000,000 with Purchasers at 5.68% per annum maturing January 24, 2030.

“On January 24, 2023, CHS Inc. (the “Company”) entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with the accredited investors signatory thereto (collectively, the “Purchasers”), pursuant to which the Company will issue and sell, in a private placement, its Series CC Senior Notes in the aggregate principal amount of $150,000,000 with a maturity date of January 24, 2030 (the “Notes”).”

CHS INC reported first quarter ended Nov. 30, 2022 results: revenue $12.8 billion, net income $782.6 million.

“reported quarterly net income of $782.6 million compared to $452.0 million in the first quarter of fiscal year 2022. Fiscal 2023 first quarter highlights include: • Revenues of $12.8 billion compared to $10.9 billion in the first quarter of fiscal year 2022, a year-over-year increase of 17%. • Continued robust global demand for commodities, coupled with market”

CHS INC: Amendments to bylaws to establish more flexibility regarding the timing and location of regional meetings for director elections (effective 2022-12-02).

“At the Annual Meeting, the members of CHS approved amendments (the "Amendments" ) to CHS’s bylaws (the "Bylaws" ) to establish more flexibility regarding the timing and location of regional meetings at which the election of a Board director occurs to ensure that CHS owners have the opportunity to participate in CHS caucuses and director elections. The Amendments to the Bylaws became effective on December 2, 2022.”

Jerrad Stroh was elected as Director at CHS INC.

“One new director, Jerrad Stroh, was also elected to the Board for a three–year term at the Annual Meeting.”

Steve Riegel retired as Director at CHS INC.

“who retired from the Board on December 2, 2022”

CHS INC reported the fiscal year ended August 31, 2022 results: revenue $47.8 billion, net income $1.7 billion.

“--- For further information Contact: Tom Ryan (651) 355-4582 Tom.Ryan@chsinc.com CHS Reports Strong Fiscal Year 2022 Earnings Net Income of $1.7 Billion and Revenues of $47.8 Billion Exceed Previous Records Strong Global Demand and Market Volatility Contributed to Increased Earnings Company Intends to Return $1 Billion Cash to Owners in Fiscal Year 2023 ST.”